Belite Bio Adr Stock Performance
| BLTE Stock | USD 57.20 1.06 1.82% |
The firm shows a Beta (market volatility) of -0.0973, which signifies not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Belite Bio are expected to decrease at a much lower rate. During the bear market, Belite Bio is likely to outperform the market. At this point, Belite Bio ADR has a negative expected return of -0.0959%. Please make sure to confirm Belite Bio's kurtosis, and the relationship between the maximum drawdown and day median price , to decide if Belite Bio ADR performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Over the last 90 days Belite Bio ADR has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound basic indicators, Belite Bio is not utilizing all of its potentials. The current stock price tumult, may contribute to shorter-term losses for the shareholders. ...more
Actual Historical Performance (%)
One Day Return (1.82) | Five Day Return (0.09) | Year To Date Return (11.67) | Ten Year Return 440.13 | All Time Return 440.13 |
1 | Breakeven On The Horizon For Belite Bio, Inc | 01/21/2025 |
2 | Belite Bio Announces 15 Million Direct Offering to Enhance Financial Position - TipRanks | 02/05/2025 |
3 | Belite Bio Inc Announces 15 Million Securities Purchase Agreement | 02/06/2025 |
4 | Belite Bio Inc Advances Phase 3 DRAGON Trial for Stargardt Disease | 02/27/2025 |
| Begin Period Cash Flow | 42.1 M |
Belite |
Belite Bio Relative Risk vs. Return Landscape
If you would invest 6,400 in Belite Bio ADR on December 1, 2024 and sell it today you would lose (574.00) from holding Belite Bio ADR or give up 8.97% of portfolio value over 90 days. Belite Bio ADR is currently does not generate positive expected returns and assumes 3.5262% risk (volatility on return distribution) over the 90 days horizon. In different words, 31% of stocks are less volatile than Belite, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Belite Bio Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Belite Bio's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Belite Bio ADR, and traders can use it to determine the average amount a Belite Bio's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0272
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | BLTE |
Estimated Market Risk
| 3.53 actual daily | 31 69% of assets are more volatile |
Expected Return
| -0.1 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.03 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Belite Bio is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Belite Bio by adding Belite Bio to a well-diversified portfolio.
Belite Bio Fundamentals Growth
Belite Stock prices reflect investors' perceptions of the future prospects and financial health of Belite Bio, and Belite Bio fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Belite Stock performance.
| Return On Equity | -0.4 | ||||
| Return On Asset | -0.26 | ||||
| Current Valuation | 1.73 B | ||||
| Shares Outstanding | 31.84 M | ||||
| Price To Book | 16.18 X | ||||
| EBITDA | (31.53 M) | ||||
| Net Income | (31.63 M) | ||||
| Cash And Equivalents | 48.7 M | ||||
| Cash Per Share | 1.96 X | ||||
| Total Debt | 886 K | ||||
| Current Ratio | 35.01 X | ||||
| Book Value Per Share | 3.63 X | ||||
| Cash Flow From Operations | (29.84 M) | ||||
| Earnings Per Share | (1.10) X | ||||
| Market Capitalization | 1.82 B | ||||
| Total Asset | 94.64 M | ||||
| Retained Earnings | (71.5 M) | ||||
| Working Capital | 86.31 M | ||||
About Belite Bio Performance
By analyzing Belite Bio's fundamental ratios, stakeholders can gain valuable insights into Belite Bio's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Belite Bio has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Belite Bio has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | (31.52) | (33.10) | |
| Return On Tangible Assets | (0.40) | (0.42) | |
| Return On Capital Employed | (0.40) | (0.42) | |
| Return On Assets | (0.38) | (0.40) | |
| Return On Equity | (0.40) | (0.38) |
Things to note about Belite Bio ADR performance evaluation
Checking the ongoing alerts about Belite Bio for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Belite Bio ADR help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Belite Bio ADR generated a negative expected return over the last 90 days | |
| Belite Bio ADR has high historical volatility and very poor performance | |
| Net Loss for the year was (31.63 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Belite Bio ADR currently holds about 48.7 M in cash with (29.84 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.96. | |
| Belite Bio ADR has a frail financial position based on the latest SEC disclosures | |
| Roughly 55.0% of the company shares are held by company insiders | |
| Latest headline from gurufocus.com: Belite Bio Inc Advances Phase 3 DRAGON Trial for Stargardt Disease |
- Analyzing Belite Bio's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Belite Bio's stock is overvalued or undervalued compared to its peers.
- Examining Belite Bio's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Belite Bio's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Belite Bio's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Belite Bio's stock. These opinions can provide insight into Belite Bio's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Belite Stock analysis
When running Belite Bio's price analysis, check to measure Belite Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Belite Bio is operating at the current time. Most of Belite Bio's value examination focuses on studying past and present price action to predict the probability of Belite Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Belite Bio's price. Additionally, you may evaluate how the addition of Belite Bio to your portfolios can decrease your overall portfolio volatility.
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation |